ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Making Sense of Antisense: The Power of Gene Silencing
This article explores antisense oligonucleotides (ASOs) in gene silencing, covering their mechanism, development, applications, pros and cons, and future delivery challenges. -
ST Pharm to construct second oligonucleotide facility in Korea
December 03, 2021The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025. -
Hoth Therapeutics and WuXi strike API and drug product deal for cancer therapeutic
November 15, 2021WuXi will use its new modality platform to provide an end-to-end solution for oligonucleotide peptide. -
Hoth Therapeutics, WuXi STA Ink API and Drug Product Pact
November 10, 2021Hoth Therapeutics, Inc., a biopharmaceutical company, has entered into two contracts with STA Pharmaceutical, a subsidiary of WuXi AppTec (WuXi STA), for process development and manufacturing... -
Asymchem Expands Oligonucleotides Mfg. Capacity
March 29, 2021API facility in Tianjin, China will accommodate gram to ton production scales with capacity to accommodate 12 or more oligo process production lines. -
UK to revolutionise oligonucleotide medicines manufacturing
February 25, 2021Collaborators on Grand Challenge 3 will utilise their combined expertise to transform the oligonucleotide supply chain.
Pharma Sources Insight January 2025
